Skip to content
Clinical Trials – home
Universita Degli Studi Di Perugia
Sponsor

Universita Degli Studi Di Perugia

Italy Piazza Dell' Universita' 1, 06123 Perugia, Italy

About the sponsor

Clinical research activity includes relapsed or refractory classical Hodgkin lymphoma, with interest in treatment settings where disease has progressed after prior therapy and in patients requiring non-standard options.

  • Ruxolitinib combinations
  • Brentuximab
  • Pembrolizumab

The focus is on achieving deeper complete response outcomes in heavily pretreated lymphoma.

About Specializations

Universita Degli Studi Di Perugia runs clinical trials in conditions such as Hairy cell leukaemia, Malignant melanoma, Hairy cell leukaemia recurrent, Hodgkin's disease refractory, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cladribine
  • Sponsor:Universita Degli Studi Di Perugia
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:North Estonia Medical Centre Foundation
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cobimetinib
  • Sponsor:Universita Degli Studi Di Perugia
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Brentuximab Vedotin
  • Sponsor:Universita Degli Studi Di Perugia

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.